These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8189971)

  • 1. [Analysis of apolipoproteins in clinical diagnosis. Standardization increases the diagnostic value].
    Berglund L; Angelin B; Eggertsen G; Eriksson M; Henriksson P
    Lakartidningen; 1994 Feb; 91(8):716-18, 723-4. PubMed ID: 8189971
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apolipoproteins and coronary heart disease].
    Beigl Y; Green P; Lurie Y
    Harefuah; 1987 Apr; 112(8):405-7. PubMed ID: 3315898
    [No Abstract]   [Full Text] [Related]  

  • 3. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoproteins and long-term prognosis in coronary heart disease patients.
    Benderly M; Boyko V; Goldbourt U
    Am Heart J; 2009 Jan; 157(1):103-10. PubMed ID: 19081405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoproteins and lipids in coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristic plots and areas.
    Zweig MH
    Arch Pathol Lab Med; 1994 Feb; 118(2):141-4. PubMed ID: 8311652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Apolipoprotein(a) phenotypes as markers of genetic susceptibility for cardiovascular risk in occupational medicine].
    Mennoia NV; Gazzaruso C; Geroldi D; Candura SM
    G Ital Med Lav Ergon; 1999; 21(3):206-17. PubMed ID: 10771732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cardiac risk factor burden in diagnosing acute coronary syndromes in the emergency department setting.
    Han JH; Lindsell CJ; Storrow AB; Luber S; Hoekstra JW; Hollander JE; Peacock WF; Pollack CV; Gibler WB;
    Ann Emerg Med; 2007 Feb; 49(2):145-52, 152.e1. PubMed ID: 17145112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum triglyceride concentration and coronary heart disease.
    Schillaci G; Pirro M; Mannarino E
    Circulation; 2002 Feb; 105(8):e54. PubMed ID: 11864938
    [No Abstract]   [Full Text] [Related]  

  • 9. Current stage of standardization of measurements of specific polypeptides and proteins discussed in light of steps needed towards a comprehensive measurement system.
    Stöckl D; Franzini C; Kratochvíla J; Middle J; Ricós C; Thienpont LM
    Eur J Clin Chem Clin Biochem; 1997 Sep; 35(9):719-32. PubMed ID: 9352236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein(a) phenotypes and their predictive value for coronary heart disease: identification of an operative cut-off of apolipoprotein(a) polymorphism.
    Gazzaruso C; Garzaniti A; Buscaglia P; Bonetti G; Falcone C; Fratino P; Finardi G; Geroldi D
    J Cardiovasc Risk; 1998 Feb; 5(1):37-42. PubMed ID: 9816554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic testing for coronary artery disease.
    Potter JA
    Lippincotts Prim Care Pract; 1999; 3(5):479-85. PubMed ID: 10795214
    [No Abstract]   [Full Text] [Related]  

  • 12. Apolipoproteins A-I and B-markers in coronary risk evaluation.
    Agoston-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
    Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoproteins.
    Fukunaga FH
    Hawaii Med J; 1988 Jun; 47(6):291. PubMed ID: 3403250
    [No Abstract]   [Full Text] [Related]  

  • 14. [How to requalify the intermediate coronary risk in high risk?].
    Simon A
    Rev Prat; 2012 Jun; 62(6):781-2. PubMed ID: 22838269
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aortic atheroma: not a sensitive indicators for coronary artery disease in patients with mitral valve disease].
    Marazanof M; Thiessard F; Laffort P; Lemieux H; Chene G; Bonnet J; Roudaut R
    Arch Mal Coeur Vaiss; 2001 Jun; 94(6):563-8. PubMed ID: 11480153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipoprotein particles LpA-I, LpA-I: A-II and LpB in coronary artery disease].
    Calvo C; Olmos A; Ulloa N; Bustos A; Toledo L; Durán D; Naveas R
    Rev Med Chil; 2000 Jan; 128(1):9-16. PubMed ID: 10883517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of estrogen status as an independent predictor of coronary artery disease presence and extent in women.
    Morise AP; Haddad WJ
    J Cardiovasc Risk; 1996 Dec; 3(6):507-11. PubMed ID: 9100086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cardiac troponin T in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis.
    Conway B; McLaughlin M; Sharpe P; Harty J
    Nephrol Dial Transplant; 2005 Dec; 20(12):2759-64. PubMed ID: 16188899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antioxidant serum levels of myocardial ischemia markers in patients with ischemic heart disease after treadmill exercise testing.
    Hasso NM; Al-Rubayi HA; El-Yassin HD
    Saudi Med J; 2005 Sep; 26(9):1473-5. PubMed ID: 16155676
    [No Abstract]   [Full Text] [Related]  

  • 20. [A comparative study of 4 diagnostic strategies in coronary artery disease. A theoretical approach].
    Henry P; Makowski S; Guermonprez JL; Guize L
    Arch Mal Coeur Vaiss; 1997 Mar; 90(3):327-35. PubMed ID: 9232070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.